ID ABCA1_MOUSE Reviewed; 2261 AA. AC P41233; B1AWZ8; DT 01-FEB-1995, integrated into UniProtKB/Swiss-Prot. DT 27-JUL-2011, sequence version 4. DT 27-MAR-2024, entry version 209. DE RecName: Full=Phospholipid-transporting ATPase ABCA1 {ECO:0000250|UniProtKB:O95477}; DE EC=7.6.2.1 {ECO:0000250|UniProtKB:O95477}; DE AltName: Full=ATP-binding cassette sub-family A member 1; DE AltName: Full=ATP-binding cassette transporter 1; DE Short=ABC-1; DE Short=ATP-binding cassette 1; GN Name=Abca1 {ECO:0000312|MGI:MGI:99607}; Synonyms=Abc1; OS Mus musculus (Mouse). OC Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia; OC Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae; OC Murinae; Mus; Mus. OX NCBI_TaxID=10090; RN [1] RP NUCLEOTIDE SEQUENCE [MRNA]. RC STRAIN=DBA/2J; TISSUE=Macrophage; RX PubMed=8088782; DOI=10.1006/geno.1994.1237; RA Luciani M.-F., Denizot F., Savary S., Mattei M.-G., Chimini G.; RT "Cloning of two novel ABC transporters mapping on human chromosome 9."; RL Genomics 21:150-159(1994). RN [2] RP NUCLEOTIDE SEQUENCE [GENOMIC DNA]. RC STRAIN=C57BL/6J; RX PubMed=11352567; DOI=10.1006/geno.2000.6467; RA Qiu Y., Cavelier L., Chiu S., Yang X., Rubin E., Cheng J.-F.; RT "Human and mouse ABCA1 comparative sequencing and transgenesis studies RT revealing novel regulatory sequences."; RL Genomics 73:66-76(2001). RN [3] RP NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]. RC STRAIN=C57BL/6J; RX PubMed=19468303; DOI=10.1371/journal.pbio.1000112; RA Church D.M., Goodstadt L., Hillier L.W., Zody M.C., Goldstein S., She X., RA Bult C.J., Agarwala R., Cherry J.L., DiCuccio M., Hlavina W., Kapustin Y., RA Meric P., Maglott D., Birtle Z., Marques A.C., Graves T., Zhou S., RA Teague B., Potamousis K., Churas C., Place M., Herschleb J., Runnheim R., RA Forrest D., Amos-Landgraf J., Schwartz D.C., Cheng Z., Lindblad-Toh K., RA Eichler E.E., Ponting C.P.; RT "Lineage-specific biology revealed by a finished genome assembly of the RT mouse."; RL PLoS Biol. 7:E1000112-E1000112(2009). RN [4] RP NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]. RA Mural R.J., Adams M.D., Myers E.W., Smith H.O., Venter J.C.; RL Submitted (SEP-2005) to the EMBL/GenBank/DDBJ databases. RN [5] RP INDUCTION BY LIPOPOLYSACCHARIDE. RX PubMed=12032171; RA Kaplan R., Gan X., Menke J.G., Wright S.D., Cai T.-Q.; RT "Bacterial lipopolysaccharide induces expression of ABCA1 but not ABCG1 via RT an LXR-independent pathway."; RL J. Lipid Res. 43:952-959(2002). RN [6] RP DOWN-REGULATION BY ENDOTOXIN. RX PubMed=12777468; DOI=10.1194/jlr.m300100-jlr200; RA Khovidhunkit W., Moser A.H., Shigenaga J.K., Grunfeld C., Feingold K.R.; RT "Endotoxin down-regulates ABCG5 and ABCG8 in mouse liver and ABCA1 and RT ABCG1 in J774 murine macrophages: differential role of LXR."; RL J. Lipid Res. 44:1728-1736(2003). RN [7] RP INTERACTION WITH MEGF10. RX PubMed=17205124; DOI=10.1371/journal.pone.0000120; RA Hamon Y., Trompier D., Ma Z., Venegas V., Pophillat M., Mignotte V., RA Zhou Z., Chimini G.; RT "Cooperation between engulfment receptors: the case of ABCA1 and MEGF10."; RL PLoS ONE 1:E120-E120(2006). RN [8] RP PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-1296, AND IDENTIFICATION BY RP MASS SPECTROMETRY [LARGE SCALE ANALYSIS]. RC TISSUE=Liver; RX PubMed=17242355; DOI=10.1073/pnas.0609836104; RA Villen J., Beausoleil S.A., Gerber S.A., Gygi S.P.; RT "Large-scale phosphorylation analysis of mouse liver."; RL Proc. Natl. Acad. Sci. U.S.A. 104:1488-1493(2007). RN [9] RP GLYCOSYLATION [LARGE SCALE ANALYSIS] AT ASN-489. RX PubMed=19349973; DOI=10.1038/nbt.1532; RA Wollscheid B., Bausch-Fluck D., Henderson C., O'Brien R., Bibel M., RA Schiess R., Aebersold R., Watts J.D.; RT "Mass-spectrometric identification and relative quantification of N-linked RT cell surface glycoproteins."; RL Nat. Biotechnol. 27:378-386(2009). RN [10] RP PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-1296, AND IDENTIFICATION BY RP MASS SPECTROMETRY [LARGE SCALE ANALYSIS]. RC TISSUE=Brain, Brown adipose tissue, Heart, Kidney, Liver, Lung, RC Spleen, and Testis; RX PubMed=21183079; DOI=10.1016/j.cell.2010.12.001; RA Huttlin E.L., Jedrychowski M.P., Elias J.E., Goswami T., Rad R., RA Beausoleil S.A., Villen J., Haas W., Sowa M.E., Gygi S.P.; RT "A tissue-specific atlas of mouse protein phosphorylation and expression."; RL Cell 143:1174-1189(2010). CC -!- FUNCTION: Catalyzes the translocation of specific phospholipids from CC the cytoplasmic to the extracellular/lumenal leaflet of membrane CC coupled to the hydrolysis of ATP. Thereby, participates in phospholipid CC transfer to apolipoproteins to form nascent high density CC lipoproteins/HDLs. Transports preferentially phosphatidylcholine over CC phosphatidylserine. May play a similar role in the efflux of CC intracellular cholesterol to apolipoproteins and the formation of CC nascent high density lipoproteins/HDLs. Translocates phospholipids from CC the outer face of the plasma membrane and forces it through its gateway CC and annulus into an elongated hydrophobic tunnel in its extracellular CC domain. {ECO:0000250|UniProtKB:O95477}. CC -!- CATALYTIC ACTIVITY: CC Reaction=ATP + H2O + phospholipidSide 1 = ADP + phosphate + CC phospholipidSide 2.; EC=7.6.2.1; CC Evidence={ECO:0000250|UniProtKB:O95477}; CC -!- CATALYTIC ACTIVITY: CC Reaction=a 1,2-diacyl-sn-glycero-3-phosphocholine(out) + ATP + H2O = a CC 1,2-diacyl-sn-glycero-3-phosphocholine(in) + ADP + H(+) + phosphate; CC Xref=Rhea:RHEA:38583, ChEBI:CHEBI:15377, ChEBI:CHEBI:15378, CC ChEBI:CHEBI:30616, ChEBI:CHEBI:43474, ChEBI:CHEBI:57643, CC ChEBI:CHEBI:456216; Evidence={ECO:0000250|UniProtKB:O95477}; CC PhysiologicalDirection=right-to-left; Xref=Rhea:RHEA:38585; CC Evidence={ECO:0000250|UniProtKB:O95477}; CC -!- CATALYTIC ACTIVITY: CC Reaction=a 1,2-diacyl-sn-glycero-3-phospho-L-serine(out) + ATP + H2O = CC a 1,2-diacyl-sn-glycero-3-phospho-L-serine(in) + ADP + H(+) + CC phosphate; Xref=Rhea:RHEA:38567, ChEBI:CHEBI:15377, CC ChEBI:CHEBI:15378, ChEBI:CHEBI:30616, ChEBI:CHEBI:43474, CC ChEBI:CHEBI:57262, ChEBI:CHEBI:456216; CC Evidence={ECO:0000250|UniProtKB:O95477}; CC PhysiologicalDirection=right-to-left; Xref=Rhea:RHEA:38569; CC Evidence={ECO:0000250|UniProtKB:O95477}; CC -!- CATALYTIC ACTIVITY: CC Reaction=a sphingomyelin(in) + ATP + H2O = a sphingomyelin(out) + ADP + CC H(+) + phosphate; Xref=Rhea:RHEA:38903, ChEBI:CHEBI:15377, CC ChEBI:CHEBI:15378, ChEBI:CHEBI:17636, ChEBI:CHEBI:30616, CC ChEBI:CHEBI:43474, ChEBI:CHEBI:456216; CC Evidence={ECO:0000250|UniProtKB:O95477}; CC PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:38904; CC Evidence={ECO:0000250|UniProtKB:O95477}; CC -!- CATALYTIC ACTIVITY: CC Reaction=ATP + cholesterol(in) + H2O = ADP + cholesterol(out) + H(+) + CC phosphate; Xref=Rhea:RHEA:39051, ChEBI:CHEBI:15377, CC ChEBI:CHEBI:15378, ChEBI:CHEBI:16113, ChEBI:CHEBI:30616, CC ChEBI:CHEBI:43474, ChEBI:CHEBI:456216; CC Evidence={ECO:0000250|UniProtKB:O95477}; CC PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:39052; CC Evidence={ECO:0000250|UniProtKB:O95477}; CC -!- ACTIVITY REGULATION: ATPase activity is decreased by cholesterol and CC ceramide. ATPase activity is stimulated by phosphatidylcholine and to a CC lesser degree by phosphatidylserine and sphingomyelin. Phospholipid CC translocase activity is highly reduced by berylium fluoride and CC aluminum flouride and reduced by N-ethylmaleimide. CC {ECO:0000250|UniProtKB:O95477}. CC -!- SUBUNIT: Interacts with MEGF10 (PubMed:17205124). May interact with CC APOE1; functionally associated with APOE1 in the biogenesis of HDLs (By CC similarity). Interacts with ABCA8; this interaction potentiates CC cholesterol efflux (By similarity). Interacts with ABCA12 and NR1H2; CC this interaction is required for ABCA1 localization to the cell surface CC and is necessary for its normal activity and stability (By similarity). CC {ECO:0000250|UniProtKB:O95477, ECO:0000269|PubMed:17205124}. CC -!- SUBCELLULAR LOCATION: Cell membrane {ECO:0000250|UniProtKB:O95477}; CC Multi-pass membrane protein {ECO:0000255}. Endosome CC {ECO:0000250|UniProtKB:O95477}. CC -!- TISSUE SPECIFICITY: Widely expressed in adult tissues. Highest levels CC are found in pregnant uterus and uterus. CC -!- INDUCTION: Down-regulated by endotoxins (LPS) or cytokines (TNF and IL- CC 1) in J774 macrophages. The down-regulation by endotoxin in macrophages CC is not likely to be mediated by the liver X receptor/retinoic X CC receptor (LXR/RXR). {ECO:0000269|PubMed:12032171}. CC -!- DOMAIN: Multifunctional polypeptide with two homologous halves, each CC containing a hydrophobic membrane-anchoring domain and an ATP binding CC cassette (ABC) domain. CC -!- PTM: Phosphorylation on Ser-2054 regulates phospholipid efflux. CC {ECO:0000250|UniProtKB:O95477}. CC -!- PTM: Palmitoylated by ZDHHC8. Palmitoylation is essential for CC localization to the plasma membrane. {ECO:0000250|UniProtKB:O95477}. CC -!- SIMILARITY: Belongs to the ABC transporter superfamily. ABCA family. CC {ECO:0000305}. CC -!- SEQUENCE CAUTION: CC Sequence=AAG39073.1; Type=Erroneous initiation; Note=Truncated N-terminus.; Evidence={ECO:0000305}; CC Sequence=CAA53530.1; Type=Erroneous initiation; Note=Truncated N-terminus.; Evidence={ECO:0000305}; CC --------------------------------------------------------------------------- CC Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms CC Distributed under the Creative Commons Attribution (CC BY 4.0) License CC --------------------------------------------------------------------------- DR EMBL; X75926; CAA53530.1; ALT_INIT; mRNA. DR EMBL; AF287263; AAG39073.1; ALT_INIT; Genomic_DNA. DR EMBL; AL772397; -; NOT_ANNOTATED_CDS; Genomic_DNA. DR EMBL; AL807243; -; NOT_ANNOTATED_CDS; Genomic_DNA. DR EMBL; CH466565; EDL02285.1; -; Genomic_DNA. DR CCDS; CCDS18187.1; -. DR PIR; A54774; A54774. DR RefSeq; NP_038482.3; NM_013454.3. DR AlphaFoldDB; P41233; -. DR SMR; P41233; -. DR BioGRID; 197900; 1. DR CORUM; P41233; -. DR IntAct; P41233; 2. DR STRING; 10090.ENSMUSP00000030010; -. DR BindingDB; P41233; -. DR ChEMBL; CHEMBL1641361; -. DR TCDB; 3.A.1.211.1; the atp-binding cassette (abc) superfamily. DR GlyConnect; 2139; 2 N-Linked glycans (1 site). DR GlyCosmos; P41233; 22 sites, 2 glycans. DR GlyGen; P41233; 22 sites, 2 N-linked glycans (1 site). DR iPTMnet; P41233; -. DR PhosphoSitePlus; P41233; -. DR SwissPalm; P41233; -. DR jPOST; P41233; -. DR MaxQB; P41233; -. DR PaxDb; 10090-ENSMUSP00000030010; -. DR PeptideAtlas; P41233; -. DR ProteomicsDB; 285949; -. DR Antibodypedia; 14760; 654 antibodies from 38 providers. DR DNASU; 11303; -. DR Ensembl; ENSMUST00000030010.4; ENSMUSP00000030010.4; ENSMUSG00000015243.5. DR GeneID; 11303; -. DR KEGG; mmu:11303; -. DR UCSC; uc008swu.1; mouse. DR AGR; MGI:99607; -. DR CTD; 19; -. DR MGI; MGI:99607; Abca1. DR VEuPathDB; HostDB:ENSMUSG00000015243; -. DR eggNOG; KOG0059; Eukaryota. DR GeneTree; ENSGT00940000154658; -. DR HOGENOM; CLU_000604_19_0_1; -. DR InParanoid; P41233; -. DR OMA; FMWNVIA; -. DR OrthoDB; 6951at2759; -. DR PhylomeDB; P41233; -. DR TreeFam; TF105191; -. DR Reactome; R-MMU-8963896; HDL assembly. DR Reactome; R-MMU-9029569; NR1H3 & NR1H2 regulate gene expression linked to cholesterol transport and efflux. DR BioGRID-ORCS; 11303; 5 hits in 79 CRISPR screens. DR ChiTaRS; Abca1; mouse. DR PRO; PR:P41233; -. DR Proteomes; UP000000589; Chromosome 4. DR RNAct; P41233; Protein. DR Bgee; ENSMUSG00000015243; Expressed in stroma of bone marrow and 256 other cell types or tissues. DR GO; GO:0016323; C:basolateral plasma membrane; ISO:MGI. DR GO; GO:0009986; C:cell surface; ISO:MGI. DR GO; GO:0030139; C:endocytic vesicle; ISO:MGI. DR GO; GO:0005768; C:endosome; ISS:UniProtKB. DR GO; GO:0009897; C:external side of plasma membrane; IDA:MGI. DR GO; GO:0005794; C:Golgi apparatus; IDA:MGI. DR GO; GO:0043231; C:intracellular membrane-bounded organelle; IDA:MGI. DR GO; GO:0097708; C:intracellular vesicle; ISO:MGI. DR GO; GO:0045121; C:membrane raft; ISO:MGI. DR GO; GO:0048471; C:perinuclear region of cytoplasm; ISO:MGI. DR GO; GO:0045335; C:phagocytic vesicle; ISO:MGI. DR GO; GO:0005886; C:plasma membrane; IDA:MGI. DR GO; GO:0140359; F:ABC-type transporter activity; IEA:InterPro. DR GO; GO:0034186; F:apolipoprotein A-I binding; ISO:MGI. DR GO; GO:0034188; F:apolipoprotein A-I receptor activity; ISO:MGI. DR GO; GO:0034185; F:apolipoprotein binding; ISO:MGI. DR GO; GO:0005524; F:ATP binding; ISO:MGI. DR GO; GO:0016887; F:ATP hydrolysis activity; IEA:InterPro. DR GO; GO:0051117; F:ATPase binding; ISO:MGI. DR GO; GO:0042626; F:ATPase-coupled transmembrane transporter activity; ISO:MGI. DR GO; GO:0120020; F:cholesterol transfer activity; IDA:MGI. DR GO; GO:0140328; F:floppase activity; ISS:UniProtKB. DR GO; GO:0008035; F:high-density lipoprotein particle binding; ISO:MGI. DR GO; GO:0031210; F:phosphatidylcholine binding; ISO:MGI. DR GO; GO:0090554; F:phosphatidylcholine floppase activity; ISS:UniProtKB. DR GO; GO:0090556; F:phosphatidylserine floppase activity; ISO:MGI. DR GO; GO:0005548; F:phospholipid transporter activity; IDA:MGI. DR GO; GO:0008320; F:protein transmembrane transporter activity; IMP:ARUK-UCL. DR GO; GO:0005102; F:signaling receptor binding; ISO:MGI. DR GO; GO:0031267; F:small GTPase binding; ISO:MGI. DR GO; GO:0046623; F:sphingolipid floppase activity; ISO:MGI. DR GO; GO:0019905; F:syntaxin binding; ISO:MGI. DR GO; GO:0007189; P:adenylate cyclase-activating G protein-coupled receptor signaling pathway; ISO:MGI. DR GO; GO:0071397; P:cellular response to cholesterol; IEA:Ensembl. DR GO; GO:0071345; P:cellular response to cytokine stimulus; IEA:Ensembl. DR GO; GO:0071222; P:cellular response to lipopolysaccharide; IDA:UniProtKB. DR GO; GO:0071300; P:cellular response to retinoic acid; IDA:UniProtKB. DR GO; GO:0071466; P:cellular response to xenobiotic stimulus; IEA:Ensembl. DR GO; GO:0033344; P:cholesterol efflux; IDA:MGI. DR GO; GO:0042632; P:cholesterol homeostasis; ISO:MGI. DR GO; GO:0008203; P:cholesterol metabolic process; IDA:MGI. DR GO; GO:0030301; P:cholesterol transport; ISO:MGI. DR GO; GO:0016197; P:endosomal transport; ISO:MGI. DR GO; GO:0051649; P:establishment of localization in cell; IMP:MGI. DR GO; GO:0140115; P:export across plasma membrane; IMP:ARUK-UCL. DR GO; GO:0007186; P:G protein-coupled receptor signaling pathway; ISO:MGI. DR GO; GO:0034380; P:high-density lipoprotein particle assembly; ISO:MGI. DR GO; GO:0032367; P:intracellular cholesterol transport; ISO:MGI. DR GO; GO:0042158; P:lipoprotein biosynthetic process; IMP:MGI. DR GO; GO:0042157; P:lipoprotein metabolic process; IMP:MGI. DR GO; GO:0007040; P:lysosome organization; ISO:MGI. DR GO; GO:0002790; P:peptide secretion; IMP:MGI. DR GO; GO:0006911; P:phagocytosis, engulfment; IMP:MGI. DR GO; GO:0033700; P:phospholipid efflux; IDA:MGI. DR GO; GO:0055091; P:phospholipid homeostasis; ISO:MGI. DR GO; GO:0045332; P:phospholipid translocation; IMP:MGI. DR GO; GO:0015914; P:phospholipid transport; ISO:MGI. DR GO; GO:0060155; P:platelet dense granule organization; ISO:MGI. DR GO; GO:0010875; P:positive regulation of cholesterol efflux; IMP:BHF-UCL. DR GO; GO:0090108; P:positive regulation of high-density lipoprotein particle assembly; IMP:UniProtKB. DR GO; GO:0009306; P:protein secretion; IMP:ARUK-UCL. DR GO; GO:0071806; P:protein transmembrane transport; IMP:ARUK-UCL. DR GO; GO:0032489; P:regulation of Cdc42 protein signal transduction; ISO:MGI. DR GO; GO:0034616; P:response to laminar fluid shear stress; ISO:MGI. DR GO; GO:0033552; P:response to vitamin B3; IEA:Ensembl. DR GO; GO:0043691; P:reverse cholesterol transport; IMP:BHF-UCL. DR GO; GO:0023061; P:signal release; IMP:ARUK-UCL. DR CDD; cd03263; ABC_subfamily_A; 2. DR Gene3D; 3.40.50.300; P-loop containing nucleotide triphosphate hydrolases; 2. DR InterPro; IPR003593; AAA+_ATPase. DR InterPro; IPR013525; ABC2_TM. DR InterPro; IPR003439; ABC_transporter-like_ATP-bd. DR InterPro; IPR017871; ABC_transporter-like_CS. DR InterPro; IPR026082; ABCA. DR InterPro; IPR027417; P-loop_NTPase. DR PANTHER; PTHR19229; ATP-BINDING CASSETTE TRANSPORTER SUBFAMILY A ABCA; 1. DR PANTHER; PTHR19229:SF34; PHOSPHOLIPID-TRANSPORTING ATPASE ABCA1; 1. DR Pfam; PF12698; ABC2_membrane_3; 2. DR Pfam; PF00005; ABC_tran; 2. DR SMART; SM00382; AAA; 2. DR SUPFAM; SSF52540; P-loop containing nucleoside triphosphate hydrolases; 2. DR PROSITE; PS00211; ABC_TRANSPORTER_1; 1. DR PROSITE; PS50893; ABC_TRANSPORTER_2; 2. DR Genevisible; P41233; MM. PE 1: Evidence at protein level; KW ATP-binding; Cell membrane; Disulfide bond; Endosome; Glycoprotein; KW Lipoprotein; Membrane; Nucleotide-binding; Palmitate; Phosphoprotein; KW Reference proteome; Repeat; Translocase; Transmembrane; KW Transmembrane helix; Transport. FT CHAIN 1..2261 FT /note="Phospholipid-transporting ATPase ABCA1" FT /id="PRO_0000093289" FT TRANSMEM 22..42 FT /note="Helical" FT /evidence="ECO:0000255" FT TOPO_DOM 43..639 FT /note="Extracellular" FT /evidence="ECO:0000250" FT TRANSMEM 640..660 FT /note="Helical" FT /evidence="ECO:0000255" FT TRANSMEM 683..703 FT /note="Helical" FT /evidence="ECO:0000255" FT TRANSMEM 716..736 FT /note="Helical" FT /evidence="ECO:0000255" FT TRANSMEM 745..765 FT /note="Helical" FT /evidence="ECO:0000255" FT TRANSMEM 777..797 FT /note="Helical" FT /evidence="ECO:0000255" FT TRANSMEM 827..847 FT /note="Helical" FT /evidence="ECO:0000255" FT TRANSMEM 941..961 FT /note="Helical" FT /evidence="ECO:0000255" FT TRANSMEM 1351..1371 FT /note="Helical" FT /evidence="ECO:0000255" FT TOPO_DOM 1372..1656 FT /note="Extracellular" FT /evidence="ECO:0000250" FT TRANSMEM 1657..1677 FT /note="Helical" FT /evidence="ECO:0000255" FT TRANSMEM 1703..1723 FT /note="Helical" FT /evidence="ECO:0000255" FT TRANSMEM 1735..1755 FT /note="Helical" FT /evidence="ECO:0000255" FT TRANSMEM 1768..1788 FT /note="Helical" FT /evidence="ECO:0000255" FT TRANSMEM 1802..1822 FT /note="Helical" FT /evidence="ECO:0000255" FT TRANSMEM 1852..1872 FT /note="Helical" FT /evidence="ECO:0000255" FT DOMAIN 899..1131 FT /note="ABC transporter 1" FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00434" FT DOMAIN 1912..2144 FT /note="ABC transporter 2" FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00434" FT REGION 69..80 FT /note="Annulus domain 1" FT /evidence="ECO:0000250|UniProtKB:O95477" FT REGION 368..379 FT /note="Annulus domain 2" FT /evidence="ECO:0000250|UniProtKB:O95477" FT REGION 564..594 FT /note="Gateway domain" FT /evidence="ECO:0000250|UniProtKB:O95477" FT REGION 1285..1310 FT /note="Disordered" FT /evidence="ECO:0000256|SAM:MobiDB-lite" FT COMPBIAS 1285..1308 FT /note="Basic and acidic residues" FT /evidence="ECO:0000256|SAM:MobiDB-lite" FT BINDING 933..940 FT /ligand="ATP" FT /ligand_id="ChEBI:CHEBI:30616" FT /ligand_label="1" FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00434" FT BINDING 1946..1953 FT /ligand="ATP" FT /ligand_id="ChEBI:CHEBI:30616" FT /ligand_label="2" FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00434" FT MOD_RES 1042 FT /note="Phosphoserine; by PKA" FT /evidence="ECO:0000250|UniProtKB:O95477" FT MOD_RES 1296 FT /note="Phosphoserine" FT /evidence="ECO:0007744|PubMed:17242355, FT ECO:0007744|PubMed:21183079" FT MOD_RES 2054 FT /note="Phosphoserine; by PKA" FT /evidence="ECO:0000250|UniProtKB:O95477" FT LIPID 3 FT /note="S-palmitoyl cysteine" FT /evidence="ECO:0000250" FT LIPID 23 FT /note="S-palmitoyl cysteine" FT /evidence="ECO:0000250" FT LIPID 1110 FT /note="S-palmitoyl cysteine" FT /evidence="ECO:0000250" FT LIPID 1111 FT /note="S-palmitoyl cysteine" FT /evidence="ECO:0000250" FT CARBOHYD 14 FT /note="N-linked (GlcNAc...) asparagine" FT /evidence="ECO:0000255" FT CARBOHYD 98 FT /note="N-linked (GlcNAc...) asparagine" FT /evidence="ECO:0000255" FT CARBOHYD 151 FT /note="N-linked (GlcNAc...) asparagine" FT /evidence="ECO:0000255" FT CARBOHYD 161 FT /note="N-linked (GlcNAc...) asparagine" FT /evidence="ECO:0000255" FT CARBOHYD 196 FT /note="N-linked (GlcNAc...) asparagine" FT /evidence="ECO:0000255" FT CARBOHYD 244 FT /note="N-linked (GlcNAc...) asparagine" FT /evidence="ECO:0000255" FT CARBOHYD 292 FT /note="N-linked (GlcNAc...) asparagine" FT /evidence="ECO:0000255" FT CARBOHYD 337 FT /note="N-linked (GlcNAc...) asparagine" FT /evidence="ECO:0000255" FT CARBOHYD 349 FT /note="N-linked (GlcNAc...) asparagine" FT /evidence="ECO:0000255" FT CARBOHYD 400 FT /note="N-linked (GlcNAc...) asparagine" FT /evidence="ECO:0000255" FT CARBOHYD 478 FT /note="N-linked (GlcNAc...) asparagine" FT /evidence="ECO:0000255" FT CARBOHYD 489 FT /note="N-linked (GlcNAc...) asparagine" FT /evidence="ECO:0000269|PubMed:19349973" FT CARBOHYD 521 FT /note="N-linked (GlcNAc...) asparagine" FT /evidence="ECO:0000255" FT CARBOHYD 820 FT /note="N-linked (GlcNAc...) asparagine" FT /evidence="ECO:0000255" FT CARBOHYD 1144 FT /note="N-linked (GlcNAc...) asparagine" FT /evidence="ECO:0000255" FT CARBOHYD 1294 FT /note="N-linked (GlcNAc...) asparagine" FT /evidence="ECO:0000255" FT CARBOHYD 1453 FT /note="N-linked (GlcNAc...) asparagine" FT /evidence="ECO:0000255" FT CARBOHYD 1499 FT /note="N-linked (GlcNAc...) asparagine" FT /evidence="ECO:0000255" FT CARBOHYD 1504 FT /note="N-linked (GlcNAc...) asparagine" FT /evidence="ECO:0000255" FT CARBOHYD 1637 FT /note="N-linked (GlcNAc...) asparagine" FT /evidence="ECO:0000255" FT CARBOHYD 2044 FT /note="N-linked (GlcNAc...) asparagine" FT /evidence="ECO:0000255" FT CARBOHYD 2238 FT /note="N-linked (GlcNAc...) asparagine" FT /evidence="ECO:0000255" FT DISULFID 75..309 FT /evidence="ECO:0000250" FT DISULFID 1463..1477 FT /evidence="ECO:0000250" FT CONFLICT 1567..1568 FT /note="Missing (in Ref. 2; AAG39073)" FT /evidence="ECO:0000305" FT CONFLICT 1568 FT /note="S -> T (in Ref. 1; CAA53530)" FT /evidence="ECO:0000305" FT CONFLICT 2024 FT /note="V -> F (in Ref. 1; CAA53530)" FT /evidence="ECO:0000305" FT CONFLICT 2024 FT /note="Missing (in Ref. 2; AAG39073)" FT /evidence="ECO:0000305" SQ SEQUENCE 2261 AA; 253912 MW; E041DA4FA73C2660 CRC64; MACWPQLRLL LWKNLTFRRR QTCQLLLEVA WPLFIFLILI SVRLSYPPYE QHECHFPNKA MPSAGTLPWV QGIICNANNP CFRYPTPGEA PGVVGNFNKS IVSRLFSDAQ RLLLYSQRDT SIKDMHKVLR MLRQIKHPNS NLKLQDFLVD NETFSGFLQH NLSLPRSTVD SLLQANVGLQ KVFLQGYQLH LASLCNGSKL EEIIQLGDAE VSALCGLPRK KLDAAERVLR YNMDILKPVV TKLNSTSHLP TQHLAEATTV LLDSLGGLAQ ELFSTKSWSD MRQEVMFLTN VNSSSSSTQI YQAVSRIVCG HPEGGGLKIK SLNWYEDNNY KALFGGNNTE EDVDTFYDNS TTPYCNDLMK NLESSPLSRI IWKALKPLLV GKILYTPDTP ATRQVMAEVN KTFQELAVFH DLEGMWEELS PQIWTFMENS QEMDLVRTLL DSRGNDQFWE QKLDGLDWTA QDIMAFLAKN PEDVQSPNGS VYTWREAFNE TNQAIQTISR FMECVNLNKL EPIPTEVRLI NKSMELLDER KFWAGIVFTG ITPDSVELPH HVKYKIRMDI DNVERTNKIK DGYWDPGPRA DPFEDMRYVW GGFAYLQDVV EQAIIRVLTG SEKKTGVYVQ QMPYPCYVDD IFLRVMSRSM PLFMTLAWIY SVAVIIKSIV YEKEARLKET MRIMGLDNGI LWFSWFVSSL IPLLVSAGLL VVILKLGNLL PYSDPSVVFV FLSVFAMVTI LQCFLISTLF SRANLAAACG GIIYFTLYLP YVLCVAWQDY VGFSIKIFAS LLSPVAFGFG CEYFALFEEQ GIGVQWDNLF ESPVEEDGFN LTTAVSMMLF DTFLYGVMTW YIEAVFPGQY GIPRPWYFPC TKSYWFGEEI DEKSHPGSSQ KGVSEICMEE EPTHLRLGVS IQNLVKVYRD GMKVAVDGLA LNFYEGQITS FLGHNGAGKT TTMSILTGLF PPTSGTAYIL GKDIRSEMSS IRQNLGVCPQ HNVLFDMLTV EEHIWFYARL KGLSEKHVKA EMEQMALDVG LPPSKLKSKT SQLSGGMQRK LSVALAFVGG SKVVILDEPT AGVDPYSRRG IWELLLKYRQ GRTIILSTHH MDEADILGDR IAIISHGKLC CVGSSLFLKN QLGTGYYLTL VKKDVESSLS SCRNSSSTVS CLKKEDSVSQ SSSDAGLGSD HESDTLTIDV SAISNLIRKH VSEARLVEDI GHELTYVLPY EAAKEGAFVE LFHEIDDRLS DLGISSYGIS ETTLEEIFLK VAEESGVDAE TSDGTLPARR NRRAFGDKQS CLHPFTEDDA VDPNDSDIDP ESRETDLLSG MDGKGSYQLK GWKLTQQQFV ALLWKRLLIA RRSRKGFFAQ IVLPAVFVCI ALVFSLIVPP FGKYPSLELQ PWMYNEQYTF VSNDAPEDMG TQELLNALTK DPGFGTRCME GNPIPDTPCL AGEEDWTISP VPQSIVDLFQ NGNWTMKNPS PACQCSSDKI KKMLPVCPPG AGGLPPPQRK QKTADILQNL TGRNISDYLV KTYVQIIAKS LKNKIWVNEF RYGGFSLGVS NSQALPPSHE VNDAIKQMKK LLKLTKDSSA DRFLSSLGRF MAGLDTKNNV KVWFNNKGWH AISSFLNVIN NAILRANLQK GENPSQYGIT AFNHPLNLTK QQLSEVALMT TSVDVLVSIC VIFAMSFVPA SFVVFLIQER VSKAKHLQFI SGVKPVIYWL SNFVWDMCNY VVPATLVIII FICFQQKSYV SSTNLPVLAL LLLLYGWSIT PLMYPASFVF KIPSTAYVVL TSVNLFIGIN GSVATFVLEL FTNNKLNDIN DILKSVFLIF PHFCLGRGLI DMVKNQAMAD ALERFGENRF VSPLSWDLVG RNLFAMAVEG VVFFLITVLI QYRFFIRPRP VKAKLPPLND EDEDVRRERQ RILDGGGQND ILEIKELTKI YRRKRKPAVD RICIGIPPGE CFGLLGVNGA GKSTTFKMLT GDTPVTRGDA FLNKNSILSN IHEVHQNMGY CPQFDAITEL LTGREHVEFF ALLRGVPEKE VGKVGEWAIR KLGLVKYGEK YASNYSGGNK RKLSTAMALI GGPPVVFLDE PTTGMDPKAR RFLWNCALSI VKEGRSVVLT SHSMEECEAL CTRMAIMVNG RFRCLGSVQH LKNRFGDGYT IVVRIAGSNP DLKPVQEFFG LAFPGSVLKE KHRNMLQYQL PSSLSSLARI FSILSQSKKR LHIEDYSVSQ TTLDQVFVNF AKDQSDDDHL KDLSLHKNQT VVDVAVLTSF LQDEKVKESY V //